CAS: 745013-59-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Tremelimumab REF: TM-T77466CAS: 745013-59-6 | SDS-PAGE:95.4%;SEC-HPLC:98.7% | 149.00 €~1,830.00 € | Thu 24 Oct 24 |
 | Tremelimumab REF: 3D-CLA1189CAS: 745013-59-6 | - - - | To inquire | Tue 05 Nov 24 |
Tremelimumab
CAS:745013-59-6
Tremelimumab, a CTLA-4 blocker, is used with Durvalumab to treat solid tumors like liver and …
Purity:
SDS-PAGE:95.4%;SEC-HPLC:98.7%
Color and Shape:
Solid
Ref: TM-T77466
| 1mg | 149.00 € | ||
| 5mg | 438.00 € | ||
| 10mg | 641.00 € | ||
| 25mg | 1,003.00 € | ||
| 50mg | 1,356.00 € | ||
| 100mg | 1,830.00 € |
Estimated delivery in United States, on Thursday 24 Oct 2024
Ref: 3D-CLA1189
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 5 Nov 2024
